Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives

University of Ottawa

$299,880.00

AI protein design for drugs and gene therapies

FY 2019-20 · 2020-03-30

Summary
Inferring the structural properties of a protein from its amino acid sequence is a challenging yet important problem in biology. Discovering these structures is important, since they determine a wide array of protein functions. However, experimental structure determination is costly and, as a result, atomic structures have only been determined for a tiny fraction of known proteins. The objective of this project is to develop an AI system capable of predicting protein-protein interaction and physicochemical properties of proteins solely from their amino acid sequences without any recourse to expensive, time-consuming and computationally prohibitive methods such as homology modelling, crystallography, nuclear magnetic resonance, molecular dynamics and macromolecular docking. The system, will allow for the design of proteins with specific properties by means of AI-based reverse engineering.
Program
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location
Ottawa|Ottawa, Ontario, Canada
Recipient Type
Academia
Business Number
119278877
Type
Grant
Source
Proactive Disclosure - Grants and Contributions

Amendments

Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.

AmendmentDateFiscal YearTotal
02020-03-302019-20$199,920.00
22020-03-302019-20$299,880.00

As published

Additional Information
This agreement has been amended 2 time. The end date of this agreements has been modified by 365 days
Additional Information (French)
Cet accord a été modifié 2 fois. La date de fin du présent accord a été changé de  365 jours.
Agreement End Date
2024-03-29
Agreement Number
947523
Agreement Start Date
2020-03-30
Agreement Title
AI protein design for drugs and gene therapies
Agreement Title (French)
Conception de protéines par IA pour la mise au point de médicaments et de thérapies géniques
Agreement Type
Grant
Agreement Value
$299,880.00
Amendment Date
2022-08-31
Amendment Number
2
Description
Inferring the structural properties of a protein from its amino acid sequence is a challenging yet important problem in biology. Discovering these structures is important, since they determine a wide array of protein functions. However, experimental structure determination is costly and, as a result, atomic structures have only been determined for a tiny fraction of known proteins. The objective of this project is to develop an AI system capable of predicting protein-protein interaction and physicochemical properties of proteins solely from their amino acid sequences without any recourse to expensive, time-consuming and computationally prohibitive methods such as homology modelling, crystallography, nuclear magnetic resonance, molecular dynamics and macromolecular docking. The system, will allow for the design of proteins with specific properties by means of AI-based reverse engineering.
Description (French)
Déduire les propriétés structurales d’une protéine à partir de sa séquence d’acides aminés est un exercice difficile, mais important en biologie. La caractérisation de ces structures est importante puisqu’elle permet de déterminer une vaste gamme de fonctions associées aux protéines. La détermination expérimentale de ces structures est néanmoins onéreuse et elle n’a été effectuée à l’échelle atomique que pour une minuscule fraction des protéines connues. L’objectif de ce projet est de mettre au point un système d’IA capable de prévoir les interactions entre les protéines et les propriétés physicochimiques de celles-ci uniquement à partir de leur séquence d’acides aminés, sans avoir recours à des méthodes onéreuses, chronophages et exigeantes sur le plan informatique comme la modélisation de l’homologie, la cristallographie, la résonance magnétique nucléaire, la dynamique moléculaire et l’amarrage macromoléculaire. Ce système permettra de concevoir des protéines qui possèdent des propriétés spécifiques grâce à l’ingénierie inverse basée sur l’IA.
Expected Results
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Expected Results (French)
À court terme, les résultats prévus seront des collaborations renforcées entre l'industrie, le milieu universitaire et le gouvernement pour soutenir l'excellence en recherche. À moyen terme, les résultats attendus seront le développement de nouvelles technologies potentiellement perturbatrices avec des collaborateurs. À long terme, trouver des solutions collaboratives aux défis des politiques publiques et créer des systèmes d'innovation plus solides.
Federal Riding
Ottawa–Vanier
Federal Riding (French)
Ottawa–Vanier
Federal Riding Number
35078
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Name (French)
Programme de collaboration en science, en technologie et en innovation - Initiatives de collaboration en R-D
Program Purpose
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.
Program Purpose (French)
Collaborer à des programmes multipartites de recherche-développement dans le but de profiter de la synergie entre la recherche transformatrice à haut risque et à haut rendement et le potentiel de découvertes scientifiques et de percées technologiques révolutionnaires dans des secteurs d’intervention prioritaires.
Recipient Business Number
119278877
Recipient City
Ottawa|Ottawa
Recipient Country
CA
Recipient Legal Name
University of Ottawa
Recipient Postal Code
K1N 6N5
Recipient Province or Territory
ON
Recipient Type
S
Reference Number
172-2019-2020-Q4-947523
University of Ottawa - $299,880 Grant (2019-20) | Canada Spends